122 related articles for article (PubMed ID: 30899384)
1. Dual-specificity phosphatase 5 suppresses ovarian cancer progression by inhibiting IL-33 signaling.
Wang L; Hu J; Qiu D; Gao H; Zhao W; Huang Y; Jiang T; Zhou J; Chen Y
Am J Transl Res; 2019; 11(2):844-854. PubMed ID: 30899384
[TBL] [Abstract][Full Text] [Related]
2. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
4. T-cell development and function are modulated by dual specificity phosphatase DUSP5.
Kovanen PE; Bernard J; Al-Shami A; Liu C; Bollenbacher-Reilley J; Young L; Pise-Masison C; Spolski R; Leonard WJ
J Biol Chem; 2008 Jun; 283(25):17362-9. PubMed ID: 18430737
[TBL] [Abstract][Full Text] [Related]
5. Dual-specificity phosphatase 5 acts as an anti-inflammatory regulator by inhibiting the ERK and NF-κB signaling pathways.
Seo H; Cho YC; Ju A; Lee S; Park BC; Park SG; Kim JH; Kim K; Cho S
Sci Rep; 2017 Dec; 7(1):17348. PubMed ID: 29229953
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 regulation of cardiac fibroblast proliferation and fibrosis by down-regulation of DUSP5.
Tao H; Yang JJ; Hu W; Shi KH; Deng ZY; Li J
Int J Biol Macromol; 2016 Jan; 82():68-75. PubMed ID: 26511729
[TBL] [Abstract][Full Text] [Related]
7. DUSP5 promotes osteogenic differentiation through SCP1/2-dependent phosphorylation of SMAD1.
Liu X; Liu X; Du Y; Hu M; Tian Y; Li Z; Lv L; Zhang X; Liu Y; Zhou Y; Zhang P
Stem Cells; 2021 Oct; 39(10):1395-1409. PubMed ID: 34169608
[TBL] [Abstract][Full Text] [Related]
8. RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-κB-IL-8 axis.
Geng R; Tan X; Wu J; Pan Z; Yi M; Shi W; Liu R; Yao C; Wang G; Lin J; Qiu L; Huang W; Chen S
Cell Death Dis; 2017 Aug; 8(8):e2994. PubMed ID: 28796265
[TBL] [Abstract][Full Text] [Related]
9. Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling.
Kovanen PE; Rosenwald A; Fu J; Hurt EM; Lam LT; Giltnane JM; Wright G; Staudt LM; Leonard WJ
J Biol Chem; 2003 Feb; 278(7):5205-13. PubMed ID: 12435740
[TBL] [Abstract][Full Text] [Related]
10. Dusp5 negatively regulates IL-33-mediated eosinophil survival and function.
Holmes DA; Yeh JH; Yan D; Xu M; Chan AC
EMBO J; 2015 Jan; 34(2):218-35. PubMed ID: 25398911
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer.
Cai C; Chen JY; Han ZD; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Zou J; Liang YX; Dai QS; Jiang FN; Zhong WD
Int J Clin Exp Med; 2015; 8(3):4186-94. PubMed ID: 26064329
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic Reticulum Stress Increases DUSP5 Expression via PERK-CHOP Pathway, Leading to Hepatocyte Death.
Jo HJ; Yang JW; Park JH; Choi ES; Lim CS; Lee S; Han CY
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491992
[TBL] [Abstract][Full Text] [Related]
13. Dual-specificity phosphatase 5-mediated fatty acid oxidation promotes Mycobacterium bovis BCG -induced inflammatory responses.
Luo J; Tian Z; Song F; Ren C; Liu W
Exp Cell Res; 2024 Jan; 434(2):113869. PubMed ID: 38049081
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis.
Tao H; Cao W; Yang JJ; Shi KH; Zhou X; Liu LP; Li J
Cardiovasc Pathol; 2016; 25(5):381-9. PubMed ID: 27318893
[TBL] [Abstract][Full Text] [Related]
15. Role of Conserved Histidine and Serine in the HCXXXXXRS Motif of Human Dual-Specificity Phosphatase 5.
Gupta A; Brahmbhatt J; Syrlybaeva R; Bodnar C; Bodnar N; Bongard R; Pokkuluri PR; Sem DS; Ramchandran R; Rathore R; Talipov MR
J Chem Inf Model; 2019 Apr; 59(4):1563-1574. PubMed ID: 30835471
[TBL] [Abstract][Full Text] [Related]
16. Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib.
Chen P; Wang J; Yao Y; Qu Y; Ji M; Hou P
Endocrine; 2024 Apr; ():. PubMed ID: 38564084
[TBL] [Abstract][Full Text] [Related]
17. LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β‑catenin signaling pathway.
Yu G; Wang W; Deng J; Dong S
Mol Med Rep; 2019 May; 19(5):3615-3621. PubMed ID: 30896797
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
Yang Q; Yu Y; Sun Z; Pan Y
Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
[TBL] [Abstract][Full Text] [Related]
19. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
[TBL] [Abstract][Full Text] [Related]
20. Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.
Cao Y; Yu Y; Chen X; Ren F; Zhang R; Jia Y; Ren Z; Sun R; Li J; Shi H
Int J Gynecol Cancer; 2018 Feb; 28(2):346-354. PubMed ID: 29324532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
